Back to Search
Start Over
325 COMPARISON EFFICACY AND SAFETY BETWEEN ATEZOLIZUMAB PLUS BEVACIZUMAB AND LENVATINIB AS FIRST-LINE SYSTEMIC THERAPY FOR HEPATOCELLULAR CARCINOMA: A REAL-WORLD STUDY.
- Source :
- Gastroenterology (00165085); 2024 Supplement, Vol. 166 Issue 5, pS-73-S-74, 1p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 00165085
- Volume :
- 166
- Issue :
- 5
- Database :
- Supplemental Index
- Journal :
- Gastroenterology (00165085)
- Publication Type :
- Academic Journal
- Accession number :
- 177027349
- Full Text :
- https://doi.org/10.1016/S0016-5085(24)00663-2